NCT07574762 Total Knee Arthroplasty With Personalized Implantation: Computer Navigation-Assisted Surgery Versus Robotic-Assisted Surgery
| NCT ID | NCT07574762 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Groupe Hospitalier Diaconesses Croix Saint-Simon |
| Condition | Osteoarthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2026-01-26 |
| Primary Completion | 2028-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2026-01-26 with a primary completion date of 2028-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Title: Personalized Total Knee Arthroplasty: Computer-Assisted Navigation vs. Robotic Assistance (CAN-ARD). Summary: Knee osteoarthritis is frequently treated with Total Knee Arthroplasty (TKA). However, approximately 20% of patients remain dissatisfied following the procedure. This study aims to compare two surgical assistance technologies designed to improve prosthetic placement accuracy: Computer-Assisted Navigation (CAN) and Robotic-Arm Assistance (RA). The primary objective is to determine if there is a significant difference in functional outcomes and the "forgotten joint" sensation (measured by the Forgotten Joint Score - FJS) between patients operated on with robotic assistance versus those with traditional navigation at 3, 12, and 24 months post-surgery. The study's hypothesis is that there is no major clinical difference between these two techniques when applied within a personalized alignment strategy.
Eligibility Criteria
Inclusion Criteria: * Patient providing written informed consent according to regulatory requirements * Male or female patients aged ≥18 years * Patients undergoing primary total knee arthroplasty for osteoarthritis * Use of Attune® prosthesis with posterior cruciate ligament retention (CR) and patellar resurfacing Exclusion Criteria: * History of ligament reconstruction * Previous fracture or bone surgery (osteotomy) of the ipsilateral femur or tibia (except hip or ankle surgery) * Preoperative knee stiffness with flexion contracture \>15° or flexion \<90° * Individuals deprived of liberty by judicial or administrative decision * Patients not affiliated with a social security system * Patients unable to understand French * Patients with cognitive impairment * Patients whose place of residence makes close clinical follow-up impossible -- Women of childbearing potential without effective contraception * Pregnant or breastfeeding women
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07574762 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07574762 currently recruiting?
Yes, NCT07574762 is actively recruiting participants. Contact the research team at ykerroumi@hopital-dcss.org for enrollment information.
Where is the NCT07574762 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT07574762 clinical trial?
NCT07574762 is sponsored by Groupe Hospitalier Diaconesses Croix Saint-Simon. The trial plans to enroll 140 participants.